A detailed history of Putnam Investments LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Putnam Investments LLC holds 25,006 shares of CSTL stock, worth $531,627. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,006
Previous 25,795 3.06%
Holding current value
$531,627
Previous $435,000 23.91%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$12.19 - $22.43 $9,617 - $17,697
-789 Reduced 3.06%
25,006 $539,000
Q3 2023

Nov 14, 2023

BUY
$13.28 - $20.3 $136,558 - $208,744
10,283 Added 66.29%
25,795 $435,000
Q2 2023

Aug 14, 2023

BUY
$11.66 - $26.0 $12,312 - $27,456
1,056 Added 7.3%
15,512 $212,000
Q1 2023

May 22, 2023

BUY
$19.47 - $28.49 $111,738 - $163,504
5,739 Added 65.84%
14,456 $328,000
Q4 2022

Feb 14, 2023

BUY
$18.08 - $30.0 $157,603 - $261,510
8,717 New
8,717 $205,000
Q1 2022

May 16, 2022

SELL
$33.17 - $46.98 $2.56 Million - $3.62 Million
-77,152 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$39.06 - $67.58 $227,836 - $394,194
5,833 Added 8.18%
77,152 $3.31 Million
Q3 2021

Nov 15, 2021

SELL
$60.13 - $77.6 $1,022 - $1,319
-17 Reduced 0.02%
71,319 $4.74 Million
Q2 2021

Aug 16, 2021

BUY
$50.07 - $76.78 $123,873 - $189,953
2,474 Added 3.59%
71,336 $5.23 Million
Q1 2021

May 17, 2021

SELL
$58.92 - $97.33 $822,110 - $1.36 Million
-13,953 Reduced 16.85%
68,862 $4.72 Million
Q4 2020

Feb 16, 2021

BUY
$43.6 - $73.05 $485,616 - $813,630
11,138 Added 15.54%
82,815 $5.56 Million
Q3 2020

Nov 16, 2020

SELL
$38.47 - $52.03 $4,616 - $6,243
-120 Reduced 0.17%
71,677 $3.69 Million
Q2 2020

Aug 14, 2020

BUY
$27.28 - $43.01 $488,257 - $769,792
17,898 Added 33.21%
71,797 $2.71 Million
Q1 2020

May 15, 2020

BUY
$23.08 - $35.53 $1.24 Million - $1.92 Million
53,899 New
53,899 $1.61 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $559M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.